Device maker looks to apply fluorescence to skin cancer detection

03/12/2013 | BioOptics World

LED Medical Diagnostics is testing tissue fluorescence technology to identify skin cancer and define surgical margins for the excision of basal cell carcinoma and squamous cell carcinoma. The company's VELscope is already FDA-approved to help determine surgical margins with cancers and precancerous lesions of the mouth.

View Full Article in:

BioOptics World

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA